Commentary on Post, < em > et al < /em > . Ultra-early tranexamic acid after subarachnoid hemorrhage: A randomized controlled trial. Lancet 2021

CONCLUSION: Ultra-early administration of TA (≤24 h) resulted in a lower rate of recurrent hemorrhage, without increasing the incidence of delayed cerebral ischemia in SAH patients.PMID:33948326 | PMC:PMC8088487 | DOI:10.25259/SNI_242_2021

Source: Surgical Neurology International - May 5, 2021 Category: Neurosurgery Authors: Benjamin W Y Lo Hitoshi Fukuda Anderson C O Tsang David J Langer Satoru Miyawaki Masaomi Koyanagi Matthew Wai-Man Lui Source Type: research